REGN421 (SAR153192)

REGN421 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN421 (SAR153192), covering 2014-03-26 to 2014-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies [Phase 1]

See pricing